| AF | Atrial fibrillation |
| AS | Aortic stenosis |
| AVIC | Aortic valve interstitial cells |
| AVR | Aortic valve replacement |
| BAV | Bicuspid aortic valve |
| BMP-2 | Bone morphogenetic protein-2 |
| BNP | B-type natriuretic peptide |
| CAD | Coronary artery disease |
| CCL4 | Chemokine (C–C motif) ligand 4 |
| HNCM | Hypertrophic non-obstructive cardiomyopathy |
| HOCM | Hypertrophic obstructive cardiomyopathy |
| LV | Left ventricle |
| LVH | Left ventricular hypertrophy |
| MMVD | Myxomatous mitral valve degeneration |
| SMAD2/3 | Mothers against decapentaplegic homolog (SMAD) family member 2/3 |
| p-SMAD2/3 | Phosphorylated-SMAD2/3 |
| TAC | Transverse aortic constriction |
| TAV | Tricuspid aortic valve |
| TAVI | Transcatheter aortic valve implantation |
| TGF-β | Transforming growth factor-β |
| VEC | Valve endothelial cells |